Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 1, Pages 33
Publisher
MDPI AG
Online
2021-12-22
DOI
10.3390/cancers14010033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019
- (2021) Laia Bruni et al. PREVENTIVE MEDICINE
- A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
- (2021) Krishna Das et al. Nature Communications
- Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines
- (2020) Alessandro Villa et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Alterations of HPV-Related Biomarkers after Prophylactic HPV Vaccination. A Prospective Pilot Observational Study in Greek Women
- (2020) George Valasoulis et al. Cancers
- Lessons learned from the INHANCE consortium: An overview of recent results on head and neck cancer
- (2020) Francesca Bravi et al. ORAL DISEASES
- Human Papillomavirus Vaccines: An Updated Review
- (2020) Liqin Cheng et al. Vaccines
- Disparities and reverse disparities in HPV vaccination: A systematic review and meta-analysis
- (2019) Jennifer C. Spencer et al. PREVENTIVE MEDICINE
- Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
- (2019) Mélanie Drolet et al. LANCET
- Human papillomavirus as a driver of head and neck cancers
- (2019) Maria Elisa Sabatini et al. BRITISH JOURNAL OF CANCER
- A Current Update on Human Papillomavirus-Associated Head and Neck Cancers
- (2019) Ebenezer Tumban Viruses-Basel
- Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases
- (2018) Max A. Cheng et al. HUMAN GENE THERAPY
- Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States
- (2018) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
- (2018) Aimée R. Kreimer et al. VACCINE
- The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis
- (2018) Lisa Mirabello et al. Viruses-Basel
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer
- (2018) Erminia Massarelli et al. JAMA Oncology
- HPV vaccines – A review of the first decade
- (2017) Diane M. Harper et al. GYNECOLOGIC ONCOLOGY
- Worldwide burden of cancer attributable to HPV by site, country and HPV type
- (2017) Catherine de Martel et al. INTERNATIONAL JOURNAL OF CANCER
- Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature
- (2017) Ankit Shah et al. POSTGRADUATE MEDICAL JOURNAL
- Gardasil-9: A global survey of projected efficacy
- (2016) Lukai Zhai et al. ANTIVIRAL RESEARCH
- Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
- (2016) M. I. E. van Poelgeest et al. CLINICAL CANCER RESEARCH
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
- (2016) Laia Bruni et al. Lancet Global Health
- Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100
- (2016) Matthew P Morrow et al. Molecular Therapy-Oncolytics
- Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites
- (2016) Vjekoslav Tomaić Cancers
- Prophylactic HPV vaccination: past, present, and future
- (2015) P. E. CASTLE et al. EPIDEMIOLOGY AND INFECTION
- A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile
- (2015) Regina Heidenreich et al. INTERNATIONAL JOURNAL OF CANCER
- Encapsulated Cellular Implants for Recombinant Protein Delivery and Therapeutic Modulation of the Immune System
- (2015) Aurélien Lathuilière et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
- (2015) Maura L. Gillison et al. JOURNAL OF CLINICAL ONCOLOGY
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I/II study of ADXS11-001 or MEDI4736 immunotherapies alone and in combination, in patients with recurrent/metastatic cervical or human papillomavirus (HPV)-positive head and neck cancer
- (2015) Ezra EW Cohen et al. Journal for ImmunoTherapy of Cancer
- Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact
- (2014) Kuan-Yin Shen et al. Expert Review of Vaccines
- Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners
- (2014) Gypsyamber D'Souza et al. JOURNAL OF CLINICAL ONCOLOGY
- HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
- (2014) Cathy Ndiaye et al. LANCET ONCOLOGY
- Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: End-of-study analysis of a Phase III randomized trial
- (2014) Mark H Einstein et al. Human Vaccines & Immunotherapeutics
- Relevance of infection with human papillomavirus: The role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins
- (2013) BRANISLAV RUTTKAY-NEDECKY et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format
- (2013) Kyle K.L. Phua et al. JOURNAL OF CONTROLLED RELEASE
- Discussing the diagnosis of HPV-OSCC: Common questions and answers
- (2013) Carole Fakhry et al. ORAL ONCOLOGY
- Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
- (2013) Rolando Herrero et al. PLoS One
- TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers
- (2012) Kelly Barrios et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
- (2011) M. R. Posner et al. ANNALS OF ONCOLOGY
- Cytoplasmic DNA innate immune pathways
- (2011) Glen N. Barber IMMUNOLOGICAL REVIEWS
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- (2011) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- HPV-associated head and neck cancer: a virus-related cancer epidemic
- (2010) Shanthi Marur et al. LANCET ONCOLOGY
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic human papillomavirus vaccines: current clinical trials and future directions
- (2008) Chien-Fu Hung et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers
- (2008) Maura L. Gillison et al. JNCI-Journal of the National Cancer Institute
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now